Novel hepatitis C virus protease inhibitors: thiazolidine derivatives

This study evaluated the inhibitory effects of thiazolidine derivatives on hepatitis C virus (HCV) protease and other human serine proteases. The inhibition efficacy was tested with a reversed-phase high-performance liquid chromatography (HPLC) assay system using a NS3-NS4A fusion protein as the HCV protease and a synthetic peptide substrate that mimics the NS5A-5B junction. Nine thiazolidine derivatives showed more than 50% inhibition at 50 microg/ml. The most potent derivative was RD4-6250, with 50% inhibition at a concentration of 2.3 microg/ml; this concentration was lower than those of other protease inhibitors reported previously. The most selective derivative was RD4-6205, with 50% inhibition at a concentration of 6.4 microg/ml, a lower concentration than those on other serine proteases (chymotrypsin, trypsin, plasmin, and elastase). These results suggest that the RD4-6205 skeleton is an important structure for inhibitory activity on the HCV protease NS3-NS4A.     

Successful surgical repair for a patient with atrial septal defect and severe pulmonary hypertension--its surgical indication and prostaglandin E1 use for postoperative pulmonary hypertensive crisis

A 45-year-old woman with atrial septal defect and pulmonary hypertension was admitted for surgical repair. Cardiac catheterization data revealed pulmonary to systemic flow ratio (Qp/Qs) of 1.81, pulmonary artery pressure (PAP) of 82/30 mmHg and pulmonary vascular resistance (PVR) of 10.8 unit. Open lung biopsy was added to evaluate pulmonary vascular obstructive disease (PVOD) which was shown Heath-Edwards grade 3 PVOD. Following closure of the defect, PAP (systolic) exceeded momentarily systemic level after cardiopulmonary bypass. Prostaglandin E1 drip was remarkably effective to bring down PAP during early postoperative period. Although PAP has not been shown significant decrease on catheterization of one year after surgery, great symptomatic improvement has been achieved.     

Exchangeability of actin in cardiac myocytes and fibroblasts as determined by fluorescence photobleaching recovery

OBJECTIVE: To assess whether hypertension is a risk factor for hysterectomy performed for benign diseases. METHODS: Self-report questionnaires were collected from 77% of 2301 Danish women aged 30, 40, 50, or 60 years selected at random in 1982 for a prevalence study. Information about cardiovascular diseases, hypertension, use of medicine, weight and dieting history, life-styles, psychologic factors, gynecologic history (including history of hysterectomy), and social background were recorded. Weight, height, and blood pressure were measured. In an incidence study, the cohort was followed during 1982-1990 via central registers to assess the incidence of hysterectomy. Logistic and Cox regressions were used to analyze data. RESULTS: In the prevalence study, history of hypertension partly explained the relation between hysterectomy and cardiovascular diseases. In the incidence study, history of hypertension and use of diuretics were significant risk factors for hysterectomy. After confounder control, use of diuretics was explained by weight-related variables, and hypertension was a risk factor for hysterectomy in educated women (adjusted relative risk [RR] 2.88, 95% confidence interval [CI] 1.07, 7.76) and in women with weight fluctuations (adjusted RR 3.31, 95% CI 1.35, 8.14). Weight cycling and lack of education remained significant risk factors for hysterectomy in women with and without hypertension, respectively. CONCLUSION: History of hypertension, weight cycling, and lack of education are closely related risk factors for premenopausal hysterectomy. These three risk factors contribute to women undergoing hysterectomy having an increased risk for cardiovascular diseases. We proposed that hypertension might be a plausible biological cause of menorrhagia and an indication for hysterectomy.     

Antiarrhythmic effect related to the plasma concentration of pentisomide in vivo and the antiarrhythmic-concentration relationship in vitro

Pentisomide, 2-(2-diisopropylaminoethyl)-4-methyl-2-(pyridyl)- pentanamide, is a novel antiarrhythmic agent structurally related to disopyramide. Using a glass bead arrhythmic model, the authors studied the antiarrhythmic effect of pentisomide in dogs by monitoring the plasma concentrations. When pentisomide was infused at 1 mg/kg/min for 20 min, the ventricular tachycardia was significantly reduced at 5 min after starting the infusion; the arrhythmias were reduced to less than 5% at the end of the 20 min infusion. The plasma-free concentration of pentisomide was about 3 micrograms/ml at 5 min; it increased to about 10 micrograms/ml at the end of 20 min infusion. With 0.3 mg/kg/min infusion, the arrhythmias were reduced to about 60% but were not significant at 20 min of infusion. The plasma-free concentration of pentisomide did not reach 3 micrograms/ml until 20 min of infusion. The 3 micrograms/ml plasma-free concentration for pentisomide seems to be a critical concentration in inducing a significant antiarrhythmic effect. Pentisomide dose-dependently inhibited ischaemia-reperfusion arrhythmia at doses of 30 microM and higher concentrations in vitro. In conclusion, pentisomide inhibits arrhythmias dependent with the plasma concentration or with the concentration of the external solution. The critical plasma-free concentration for inhibition of arrhythmias was 3 micrograms/ml (not equal to 10 microM) and the in vitro effect also had a similar concentration. Therefore, the in vivo and in vitro antiarrhythmic concentrations were well correlated.     

Characterization of electrodeposited WO3 films and its application to electrochemical wastewater treatment

WO₃ films have been prepared on to IrO₂-coated Ti substrate by cathodic deposition, and as-deposited and annealed films have been characterized using XRD, TEM, Raman and FT-IR spectroscopy. The as-deposited film consists of nanocrystalline, orthorhombic WO₃·H₂O and this phase transforms to amorphous WO₃ by annealing at 250 °C and to monoclinic WO₃ by annealing at and above 350 °C. The as-deposited and annealed films have been used as anodes for electrochemical decomposition of phenol in aqueous solutions with and without chloride ions. The monoclinic WO₃ anodes prepared by annealing at 350 and 400 °C show relatively high electrochemical activity in the chloride-containing solution. In addition, the anodes possess high chemical and physical stabilities: very low dissolution rate of WO₃ during the electrolysis and good adhesion to the substrate. Thus, WO₃ anodes may be promising materials for anodic oxidation of bio-refractory organics in wastewater, although further improvement of electrochemical activity is needed for more effective decrease in total organic carbons in wastewater.     

Mechanism of electrodeposition of copper from cupric pyrophosphate solutions

Cathodic polarization curves were measured for copper in cupric pyrophosphate solutions of different concentrations and temperatures. A rotating disc electrode was used to eliminate concentration polarization. For all solutions, two potential regions are distinguishable in the polarization curve; one is less negative than a critical potential E_b around ?0.75 V vs sce (Region I) and the other more negative than E_b (Region II). A weak adsorption of pyrophosphate ions and hence some inhibition of the electrodeposition of copper is expected for Region I but there is no adsorption in Region II. The exchange current density i_o for the copper deposition was obtained by extrapolating the Tafel relation observed in Region II to the rest potential corresponding to the equilibrium potential. The following reaction mechanisms are proposed to explain the dependence of i_o on the concentration of Cu(P₂O₇)^6?₂ and P₂O^4?₇ ions.

Apparent activation energies are estimated to be about 11 kcal/mol in both cases.     

Si-C-O glass-like compound/exfoliated graphite composites for negative electrode of lithium ion battery

Two low molecular weight silicone compounds, a cyclic type having vinyl groups and a chain-type having Si-H bonds, a catalyst for curing, and a catalyst regulator were mixed. The mixture was impregnated into exfoliated graphite (EG) by sorption, and cured in air at 200 °C. By this process cross-linked silicone coatings were formed on graphite flakes. The composites of Si-C-O glass-like compounds and EG were synthesized by heat treatment of this precursor at 1000-1400 °C for 1 h in argon. The composites formed at 1000-1300 °C were amorphous by XRD and had practically the same chemical composition: Si 44-45, C 27-29, O 25-26, H < 0.5, all in mass%. The ²⁹Si MAS-NMR spectra indicated that the compound formed at 1000 °C was mainly composed of siloxane bonds and amorphous silica, whereas in the compound formed at 1300°C, Si-C bonds and amorphous silica were predominant. The insertion/extraction characteristics of lithium ions for the electrode prepared with composite:poly(vinylidene fluoride) = 90:10 mass% were examined in 1 mol L⁻¹ LiClO₄ solution of ethylene carbonate:diethyl carbonate = 50:50 vol%. High, 650-700 mA h g⁻¹, capacities and steady cycle performance at 50 mA g⁻¹ were achieved with the composites formed at 1250-1300 °C. Capacities of the composites formed at 1200 °C and lower were initially higher but decreased with increasing number of cycles. The composites formed at 1350 °C showed good cycle performance but the capacity was about 500 mA h g⁻¹ due to the formation of β-SiC. Except for the first cycle, the capacity-potential characteristics were similar to those of hard carbons and the coulomb efficiency was 95-100%. For all the composites the capacity was larger than that of graphite (372 mA h g⁻¹) in the range of 50-200 mA g⁻¹. Due to the large insertion capacity of the first cycle, the efficiency was low (60-70%) at first. By short-circuiting the working electrode to the lithium foil counter electrode for a certain period, the irreversible capacity of the first cycle was almost eliminated. It indicates that direct doping of lithium ions into composites is a promising way to increase the efficiency of the first cycle.